PATENT CLAIM ANALYSIS

Application Number: 15874592
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "277000"]

Abstract:
The present invention provides a method of treating one or more sodium channel related diseases or disorders in an individual, including related symptoms. The method comprises administering to the individual a tetrahydropyridine derivative in an amount effective to treat sodium channel related diseases or disorders in individuals. These compounds are generally categorised as Ritalin related compounds. The present invention also provides compounds for use in the treatment of and also for use in the manufacture of a medicament for the treatment of sodium channel related diseases or disorders in an individual. A method is further provided for the preparation and isolation of the derivatives of the compound of the present invention.

Claim (Index 6):
The method according to  claim 1 , wherein R is a p-bromo.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 86.0
- Lexical Diversity: 2.12727
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15522510', '14355552', '15561674', '12984318', '13580129']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6870300357199519
- 35 USC 102 Novelty (BERT): 0.539935017976438
- Combined Prediction Score: 0.6723205339456005
- Mean Citation Score: 235.342438
- Max Citation Score: 371.80396
- Similarity Product: 184.85456209327103

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test